Tonix Pharmaceuticals to Participate in Fireside Chat at the Oppenheimer 26th Annual Healthcare Conference
December 01, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Dec. 1, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder...
Tonix Pharmaceuticals Presents Additional Data on Tonmya(TM) Demonstrating Improvements in Sleep, Pain, and Other Outcomes in Fibromyalgia at 2015 ACR/ARHP Annual Meeting
November 10, 2015 08:30 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder...
Tonix Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Programs Update
November 09, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder...
Tonix Pharmaceuticals Announces Acceptance of Three Abstracts to be Presented at the 2015 ACR/ARHP Annual Meeting
October 01, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder,...
Tonix Pharmaceuticals to Present at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment
September 24, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Sept. 24, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder, and...
Tonix Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference
September 08, 2015 07:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder,...
Tonix Pharmaceuticals Presents on the Development of TNX-102 SL for Post-Traumatic Stress Disorder (PTSD) at the 2015 Military Health System Research Symposium
August 18, 2015 13:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Aug. 18, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix") today presented an overview of its development of TNX-102 SL (cyclobenzaprine HCl sublingual...
Tonix Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Program Update
August 10, 2015 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), a clinical-stage pharmaceutical company developing next-generation medicines for fibromyalgia,...
Tonix Pharmaceuticals Appoints Mark T. Edgar, PhD as Senior Vice President of Product Development
July 21, 2015 07:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, July 21, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), a clinical-stage company developing next-generation medicines for fibromyalgia, post-traumatic...
Tonix Pharmaceuticals Closes $20.1 Million Public Offering of Common Stock
July 17, 2015 12:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, July 17, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix") today announced the closing of its previously announced underwritten public offering of...